November 21, 2024
Q&A with the Care Team: Get to Know our Nurse Practitioners and Navigators
Nurse navigators and nurse practitioners are crucial members of our team at the N.C. Basnight Cancer Hospital, UNC Lineberger’s clinical home.
Tag: Pancreatic Cancer Center of Excellence
October 15, 2024
Milner awarded $2.79 million NIH grant to study epigenetic regulation of T cell exhaustion
The NIH has awarded a five-year, $2.79 million R01 research grant to Justin Milner, PhD, to define how a druggable family of epigenetic regulators control T cell activity.
October 7, 2024
Serody and Yeh honored with Battle Distinguished Cancer Research Award
Jonathan Serody, MD, and Jen Jen Yeh, MD, were named the 2023 recipients of the Hyman L. Battle Distinguished Cancer Research Award, recognizing their significant scientific achievements.
September 23, 2024
Rashid awarded grant to develop AI tool that recommends optimal clinical trials to pancreatic cancer patients
Naim Rashid, PhD, has received a Department of Defense Pancreatic Cancer Research Program pilot award to build an AI tool that generates personalized clinical trial recommendations for patients with PDAC.
June 28, 2024
Scientific symposium highlights latest developments in pancreatic cancer research
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.
June 6, 2024
Molecular pathway that impacts pancreatic cancer progression and response to treatment detailed
UNC Lineberger researchers have established the most comprehensive molecular portrait of the workings of KRAS, a key cancer-causing gene, and how its activities impact pancreatic cancer outcomes.
June 6, 2024
Inside Precision Medicine: Most Comprehensive Molecular KRAS Portrait to Date Can Inform Pancreatic Cancer Treatment Response
March 4, 2024
Yeh, Johnson awarded five-year, $3.2 million research grant from NCI
The grant will support the first metastatic pancreatic cancer trial in the country to evaluate whether selecting treatment by tumor subtype will help patients match to more effective first-line therapies.
February 16, 2024
PROCLAIM Study open to accrual
The PROmoting CLinicAl TrIal EngageMent for Pancreatic Cancer App Study (PROCLAIM Study), which is focused on breaking down barriers to diverse clinical trial population recruitment, is enrolling patients.
January 9, 2024